Newby, D E <br/><br/>
Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition.  [electronic resource] 

 -  European heart journal  Dec 1998 
 - 1808-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0195-668X 
<br/><br/><label>Standard No.: </label>10.1053/euhj.1998.1201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Blood Pressure--drug effects<br/>Double-Blind Method<br/>Exercise Test<br/>Exercise Tolerance--drug effects<br/>Female<br/>Heart Failure--drug therapy<br/>Humans<br/>Indans--therapeutic use<br/>Male<br/>Middle Aged<br/>Neprilysin--antagonists & inhibitors<br/>Propionates--therapeutic use<br/>Protease Inhibitors--therapeutic use<br/>Time Factors